{"name":"Frantz Viral Therapeutics, LLC","slug":"frantz-viral-therapeutics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Artesunate vaginal insert","genericName":"Artesunate vaginal insert","slug":"artesunate-vaginal-insert","indication":"Malaria","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Placebo vaginal insert","genericName":"Placebo vaginal insert","slug":"placebo-vaginal-insert","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Artesunate vaginal insert","genericName":"Artesunate vaginal insert","slug":"artesunate-vaginal-insert","phase":"phase_2","mechanism":"Artesunate is a derivative of artemisinin that targets the heme moiety of the malaria parasite, disrupting its 80-kDa protein.","indications":["Malaria"],"catalyst":""},{"name":"Placebo vaginal insert","genericName":"Placebo vaginal insert","slug":"placebo-vaginal-insert","phase":"phase_3","mechanism":"A placebo vaginal insert contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}